250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 10 Community Angel Investors in United Arab Emirates in April 2025

A list of 10 angel investors that invest in Community startups based in United arab emirates. We rank investors based on the number of investments they made in Community companies from United arab emirates. We update this investor list every month.

Top 10 Community Angel Investors in United Arab Emirates in April 2025

Investor Community United Arab Emirates investments
Manu Gupta 1
Oskar Hartmann 1
Klaus Hommels 1
Max Burger 1
Nadia Mannell 1
Paul Sherry 1
Ivanka Trump 1
Sarper Tanli 1
Priya Oberoi 1
Basim Anwer 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Manu Gupta Angel · London, England, United Kingdom
Manu is the founder of Blue Lion Global VC, and was previously a founding member and Partner of Lakestar VC (>$1.4bn). He splits time between San Francisco and London.
Show more
Investment focus
  • Financial Services, FinTech, Software
  • Seed, Series A, Series B
  • United States, India, Germany
Portfolio highlights
  • 5Mins — 5Mins is the new microlearning platform that helps your employees build in-demand skills fast with AI-powered personalisation and advanced gamification.
  • Vetic — Vetic is a network of cutting-edge clinics with an emphasis on providing comprehensive pet health care.
  • Sunhero — Sunhero delivers custom-built solar panel solutions. Sunhero offers consumers a hassle-free method of installing customised photovoltaic solar systems on their homes, be that either purchasing outright or renting for a 20 year period.
Oskar Hartmann Angel · Moscow, Moscow City, Russian Federation
Oskar Hartmann currently works as an Angel Investor for YAP. He previously worked at Flaschenpost SE as an Investor. Oskar Hartmann attended WHU - Otto Beisheim School of Management.
Show more
Investment focus
  • E-Commerce, Internet, Automotive
  • Seed, Series A, Pre-Seed
  • Germany, Russian Federation, India
Portfolio highlights
  • Tiggy — 15 minute grocery delivery on a mission to forever change the way we buy everyday essentials. Now live in Vancouver
  • Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
  • June Homes — June Homes is a network of fully furnished bedrooms in prime spots available on flexible month-to-month terms in major American cities.
Klaus Hommels Angel · Zürich, Zurich, Switzerland
Klaus Hommels is Founder of Lakestar. Lakestar invests in European as well as U.S. companies that show fast international growth. Klaus has been involved in the early days of investments such as Skype, Xing, King, Facebook, Spotify and Airbnb. More recent investments include online men's grooming business Harry's, GoEuro, Opendoor andFiveAI. Klaus started his career at Bertelsmann, before joining AOL Germany in 1995 as a Board Member. He was also a venture partner of Benchmark Capital Europe. He earned his MBA and PhD in finance from the University of Fribourg in Switzerland. He was ranked as one of the top Europe-based venture capital investors in the global Midas List 2013, 2014 and 2015 and just became third best European investor in the first European list of the same ranking. Lakestar is the leading European VC with a true global presence with offices in Zurich, Berlin and London as well as satellites in New York and Hong Kong. Klaus has a strong voice in the European Tech Ecosystems which he supports passionately with various initiatives, eg. the 'Internet Foundation'.Klaus started his career at Bertelsmann, before joining AOL Germany in 1995 as a Board Member. He was also a venture partner of Benchmark Capital Europe. He earned his MBA and PhD in finance from the University of Fribourg in Switzerland. He was ranked as one of the top Europe-based venture capital investors in the global Midas List 2013, 2014 and 2015 and just became third best European investor in the first European list of the same ranking. Lakestar is the leading European VC with a true global presence with offices in Zurich, Berlin and London as well as satellites in New York and Hong Kong. Klaus has a strong voice in the European Tech Ecosystems which he supports passionately with various initiatives, eg. the 'Internet Foundation'.
Show more
Investment focus
  • E-Commerce, Software, News
  • Series A, Seed, Funding Round
  • Germany, United Kingdom, Sweden
Portfolio highlights
  • Enfore — EnFour is a business platform paired with a collection of versatile, easy to use apps that run on smartphones, tablets and personal computers. It was founded in 2009 by Marco Boerries. Enfour's solution creates a level playing field by giving small businesses instant access to the tools, capabilities insights normally only available to largercompanies. Their goal is to provide the majority of small businesses around the world with similar efficiencies and scale effects to those that large enterprises possess. They founded enfore to re-imagine how these businesses utilize technology and to enable them to stay competitive in a connected world. By combining innovative hardware, powerful and easy to use software as well as comprehensive services, enfore delivers an amazing solution to connect all business aspects.
  • Citra Style — Citra Style designs and produces fashion for Muslim Women that follows contemporary runway and mainstream trends. Products are available both online and offline across the globe, with strong footprint in USA, Canada, United Kingdom, and Germany. The quality of merchandise is considered best in the segment.Citra Style’s fashion experts combinefashion items to looks which are made available online in a distinguished “Shop-By-Look” feature to inspire online shoppers.The team consists of Western born/raised Muslims with extensive fashion and ecommerce experience. Citra Style has a solid investor base that will help grow the company into a Multi 100 million USD business.
  • Factory Berlin — Factory Berlin is the strongest innovation network in Europe: a curated community of 3500+ creators from the world of startups, tech, and corporates.
Max Burger Angel
Max Burger is an Angel Investor in Asia, Europe and the United States. He is the co-owner of FMCG.
Show more
Investment focus
  • B2B, SaaS, Enterprise Software
  • Seed, Angel, Series A
  • United States, Spain, Mexico
Portfolio highlights
  • Smartvel — Are you looking to boost your marketing and SEO strategy? Check out our curated travel content solutions with AI. More information here!
  • Clara — End-to-end spend management for companies in Latin America.
  • Managed by Q — Keep your workplace running smoothly with Eden Workplace's all-in-one workplace management and desk booking software. Discover how Eden Workplace's suite of solutions can streamline your workflow today!
Nadia Mannell Angel · Dubai, Dubai, United Arab Emirates
Nadia Mannell Founding General Partner of Seed South Capital.
Show more
Investment focus
  • Women's, mHealth, Health Care
  • Seed
  • United Arab Emirates
Portfolio highlights
  • Nabta Health — Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs.The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations.Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC).NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes.Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes.Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Paul Sherry Angel · Dubai, Dubai, United Arab Emirates
Paul Sherry
Show more
Investment focus
  • Social, Software, Mental Health
  • Pre-Seed
  • United Arab Emirates
Portfolio highlights
  • EaseUp — EaseUp makes building social confidence easy and fun. Our app turns exposure therapy into a gamified experience, rooted in science - accessible to all.
Ivanka Trump Angel · New York, New York, United States
Ivanka Trump
Show more
Investment focus
  • Education, Farming, CleanTech
  • Seed, Pre-Seed, Series A
  • United States, United Arab Emirates
Portfolio highlights
  • Twigtale — Twigtale is the first company to provide parents with personalized, high-quality, accessible expert advice for every major transition a child undergoes, such as welcoming a new baby, moving, even experiencing death or cancer. The personalized stories are scripted by child development experts, then personalized by parents. The books are engaging forkids and a powerful playbooks for parents. Customers are parents, groups, partners & sponsors.
  • HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.
  • University of The Community/ Indigenous Cultural Arts Museum — UNIVERSITY FOR SELF LEARNING
Sarper Tanli Angel · Dubai, Dubai, United Arab Emirates
Sarper brings over 28 years of experience in medical and healthcare management, planning, and development, and operations. He holds a Medical Doctor and a Masters in Healthcare Administration degree from Istanbul University as well as a Ph.D. degree in Healthcare Management from Marmara University. He worked in International divisions of HoustonMethodist Hospital Global and Harvard Medical International in the region during the last 15 years. Dr. Sarper started the first home health and disease management company in Turkey in early 2002. He has held key positions in the development of Dubai Healthcare City.
Show more
Investment focus
  • Women's, mHealth, Health Care
  • Seed
  • United Arab Emirates
Portfolio highlights
  • Nabta Health — Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs.The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations.Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC).NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes.Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes.Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Priya Oberoi Angel
Priya Oberoi Founding Partner at Oberoi Capital Partners, Entrepreneur and Angel Investor.
Show more
Investment focus
  • Women's, mHealth, Software
  • Seed
  • United Kingdom, United Arab Emirates
Portfolio highlights
  • Anya — NHS-trusted healthcare support with 24/7 expert guidance, innovative tools, employee benefits, and trusted healthcare partnerships worldwide.
  • Nabta Health — Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs.The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations.Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC).NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes.Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes.Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Basim Anwer Angel · Dubai, Dubai, United Arab Emirates
Basim Anwer of Regionality Group of Companies.
Show more
Investment focus
  • Women's, mHealth, Health Care
  • Seed
  • United Arab Emirates
Portfolio highlights
  • Nabta Health — Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs.The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations.Moreover, NCDs leave populations more susceptible to communicable diseases such as coronaviruses, influenza and tuberculosis. During the COVID-19 pandemic of 2020, 78% of people admitted to ICU in the US and 94% of those who died had underlying health conditions (CDC).NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Only since 1994, when the United States’ National Institutes of Health (NIH) mandated that women and minorities were to be included as subjects in clinical research, has the research community entertained the fact that sex and/or gender differences might affect clinical outcomes.Today, women using drugs that were approved by the early 90s, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes.Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to achieve a formal diagnosis of PCOS within 90 days. The average time taken to diagnose PCOS currently is 2.5 years.
Investors by industry
Investors by country
Angel Investors in United Arab Emirates by industry